Ontrak Research and Development Expenses 2010-2024 | OTRK

Ontrak research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Ontrak Annual Research and Development Expenses
(Millions of US $)
2024 $5
2023 $7
2022 $11
2021 $18
2020 $13
2019 $5
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Ontrak Quarterly Research and Development Expenses
(Millions of US $)
2024-12-31 $1
2024-09-30 $1
2024-06-30 $1
2024-03-31 $1
2023-12-31 $2
2023-09-30 $2
2023-06-30 $2
2023-03-31 $2
2022-12-31 $2
2022-09-30 $3
2022-06-30 $3
2022-03-31 $3
2021-12-31 $5
2021-09-30 $5
2021-06-30 $4
2021-03-31 $5
2020-12-31 $5
2020-09-30 $4
2020-06-30 $2
2020-03-31 $2
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30 $2
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31 $0
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.006B $0.011B
Ontrak, Inc. is an AI and telehealth enabled, virtualized outpatient healthcare treatment company. The company's Predict-Recommend-Engage(TM) platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways. Ontrak, Inc., formerly known as Catasys Inc., is based in United States.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.282B 18.36
DaVita (DVA) United States $11.202B 14.29
Encompass Health (EHC) United States $10.408B 23.33
Chemed (CHE) United States $8.501B 27.28
Option Care Health (OPCH) United States $5.259B 25.21
Elanco Animal Health (ELAN) United States $4.190B 9.27
RadNet (RDNT) United States $3.686B 79.02
Amedisys (AMED) United States $3.011B 21.29
LifeStance Health (LFST) United States $2.576B 0.00
Addus HomeCare (ADUS) United States $1.840B 21.32
Astrana Health (ASTH) United States $1.573B 35.26
U.S Physical Therapy (USPH) United States $1.025B 26.14
Pennant (PNTG) United States $0.907B 36.29
Aveanna Healthcare Holdings (AVAH) United States $0.886B 0.00
Atai Life Sciences (ATAI) Germany $0.294B 0.00
Daxor (DXR) United States $0.036B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00